Bank Of Montreal Apellis Pharmaceuticals, Inc. Transaction History

Bank Of Montreal

$202 Billion
Q4 2024

A detailed history of Bank Of Montreal transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 80,991 shares of APLS stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

80,991

Previous 39,356 105.79%

Holding current value

$2.22 Million

Previous $1.14 Million 127.67%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$26.18 - $35.42 $1.09 Million - $1.47 Million	41,635 Added 105.79%	80,991 $2.58 Million
Q3 2024 Nov 13, 2024	SELL	$28.84 - $41.15 $2.68 Million - $3.83 Million	-92,962 Reduced 70.26%	39,356 $1.14 Million
Q2 2024 Aug 14, 2024	SELL	$38.07 - $59.71 $23,565 - $36,960	-619 Reduced 0.47%	132,318 $5.08 Million
Q1 2024 May 13, 2024	SELL	$55.39 - $72.47 $18.7 Million - $24.4 Million	-336,947 Reduced 71.71%	132,937 $7.81 Million
Q4 2023 Feb 08, 2024	BUY	$37.14 - $64.82 $1.41 Million - $2.46 Million	37,911 Added 8.78%	469,884 $28.1 Million
Q3 2023 Nov 01, 2023	BUY	$23.65 - $89.22 $8.37 Million - $31.6 Million	354,047 Added 454.34%	431,973 $16.4 Million
Q2 2023 Aug 02, 2023	SELL	$76.68 - $93.31 $1.76 Million - $2.15 Million	-23,005 Reduced 22.79%	77,926 $7.1 Million
Q1 2023 Jun 13, 2024	BUY	$46.59 - $66.96 $3.43 Million - $4.93 Million	73,611 Added 55.37%	206,548 $13.6 Million
Q4 2022 Feb 01, 2023	SELL	$43.24 - $61.04 $1.23 Million - $1.73 Million	-28,408 Reduced 21.96%	100,931 $5.22 Million
Q3 2022 Nov 10, 2022	SELL	$44.76 - $69.66 $1.74 Million - $2.7 Million	-38,786 Reduced 23.07%	129,339 $8.92 Million
Q2 2022 Aug 11, 2022	BUY	$35.07 - $59.21 $631 - $1,065	18 Added 0.01%	168,125 $7.81 Million
Q1 2022 May 12, 2022	SELL	$35.46 - $54.12 $410,414 - $626,384	-11,574 Reduced 6.44%	168,107 $8.33 Million
Q4 2021 Feb 11, 2022	SELL	$30.74 - $49.16 $2.27 Million - $3.63 Million	-73,847 Reduced 29.13%	179,681 $8.77 Million
Q3 2021 Nov 12, 2021	SELL	$31.4 - $69.84 $30,301 - $67,395	-965 Reduced 0.38%	253,528 $8.61 Million
Q2 2021 Aug 12, 2021	BUY	$40.9 - $64.9 $10.4 Million - $16.5 Million	254,493 New	254,493 $16.3 Million

Others Institutions Holding APLS

# of Institutions

304

Shares Held

117M

Call Options Held

3.03M

Put Options Held

1.05M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.01B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account